Do analysts prefer OM or MODD?

Outset Medical presently has a consensus target price of $10.00, suggesting a potential upside of 146.91%. Given Outset Medical's stronger consensus rating and higher probable upside, equities analysts clearly believe Outset Medical is more favorable than Modular Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Outset Medical 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Modular Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts rate NNOX or MODD?

Nano-X Imaging presently has a consensus target price of $4.33, suggesting a potential upside of 705.75%. Given Nano-X Imaging's stronger consensus rating and higher possible upside, equities analysts clearly believe Nano-X Imaging is more favorable than Modular Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nano-X Imaging 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.50 Modular Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Do analysts recommend NYXH or MODD?

Nyxoah currently has a consensus price target of $4.26, suggesting a potential upside of 213.38%. Given Nyxoah's stronger consensus rating and higher possible upside, research analysts plainly believe Nyxoah is more favorable than Modular Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nyxoah 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Modular Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is NYXH or MODD more profitable?

Modular Medical has a net margin of 0.00% compared to Nyxoah's net margin of -443.16%. Nyxoah's return on equity of -178.90% beat Modular Medical's return on equity. Company Net Margins Return on Equity Return on Assets Nyxoah -443.16% -178.90% -81.83% Modular Medical N/A -292.14% -222.79%

Does the media favor NYXH or MODD?

In the previous week, Nyxoah had 1 more articles in the media than Modular Medical. MarketBeat recorded 3 mentions for Nyxoah and 2 mentions for Modular Medical. Nyxoah's average media sentiment score of 0.95 beat Modular Medical's score of 0.00 indicating that Nyxoah is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nyxoah 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Modular Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate MDAI or MODD?

Spectral AI presently has a consensus target price of $4.00, suggesting a potential upside of 142.42%. Given Spectral AI's stronger consensus rating and higher possible upside, analysts clearly believe Spectral AI is more favorable than Modular Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Spectral AI 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.67 Modular Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media favor MDAI or MODD?

In the previous week, Spectral AI had 1 more articles in the media than Modular Medical. MarketBeat recorded 3 mentions for Spectral AI and 2 mentions for Modular Medical. Spectral AI's average media sentiment score of 0.00 equaled Modular Medical'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Spectral AI 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Modular Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend MODD or COCH?

Envoy Medical has a consensus target price of $2.17, suggesting a potential upside of 229.38%. Given Envoy Medical's stronger consensus rating and higher probable upside, analysts clearly believe Envoy Medical is more favorable than Modular Medical. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Modular Medical 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Envoy Medical 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Does the media refer more to MODD or COCH?

In the previous week, Envoy Medical had 4 more articles in the media than Modular Medical. MarketBeat recorded 6 mentions for Envoy Medical and 2 mentions for Modular Medical. Envoy Medical's average media sentiment score of 0.64 beat Modular Medical's score of 0.00 indicating that Envoy Medical is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Modular Medical 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Envoy Medical 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Modular Medical (MODD) Competitors

$2.72 +0.06 (+2.26%)

Closing price 10/9/2026 04:00 PM Eastern

Extended Trading

$2.63 -0.09 (-3.20%)

As of 10/9/2026 07:48 PM Eastern

Compare

MODD vs. OM, NNOX, NYXH, MDAI, and COCH

Should you buy Modular Medical stock or one of its competitors? Modular Medical's main competitors and comparable companies include Outset Medical (OM), Nano-X Imaging (NNOX), Nyxoah (NYXH), Spectral AI (MDAI), and Envoy Medical (COCH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Modular Medical compare to Outset Medical?

Outset Medical (NASDAQ:OM) and Modular Medical (NASDAQ:MODD) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, valuation, risk, dividends, analyst recommendations, institutional ownership and media sentiment.

Outset Medical has a beta of 1.99, meaning that its share price is 99% more volatile than the broader market. Comparatively, Modular Medical has a beta of 0.51, meaning that its share price is 49% less volatile than the broader market.

Modular Medical has lower revenue, but higher earnings than Outset Medical. Outset Medical is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Outset Medical	$119.48M	0.64	-$81.65M	-$4.09	N/A
Modular Medical	N/A	N/A	-$28.24M	-$8.69	N/A

In the previous week, Modular Medical had 1 more articles in the media than Outset Medical. MarketBeat recorded 2 mentions for Modular Medical and 1 mentions for Outset Medical. Outset Medical's average media sentiment score of 0.51 beat Modular Medical's score of 0.00 indicating that Outset Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Outset Medical	Positive
Modular Medical	Neutral

Modular Medical has a net margin of 0.00% compared to Outset Medical's net margin of -63.06%. Outset Medical's return on equity of -61.67% beat Modular Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Outset Medical	-63.06%	-61.67%	-28.25%
Modular Medical	N/A	-292.14%	-222.79%

27.5% of Modular Medical shares are held by institutional investors. 2.5% of Outset Medical shares are held by company insiders. Comparatively, 2.3% of Modular Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Outset Medical presently has a consensus target price of $10.00, suggesting a potential upside of 146.91%. Given Outset Medical's stronger consensus rating and higher probable upside, equities analysts clearly believe Outset Medical is more favorable than Modular Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Modular Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Outset Medical beats Modular Medical on 10 of the 15 factors compared between the two stocks.

How does Modular Medical compare to Nano-X Imaging?

Nano-X Imaging (NASDAQ:NNOX) and Modular Medical (NASDAQ:MODD) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, profitability, dividends, institutional ownership, media sentiment, risk and earnings.

Nano-X Imaging has a beta of 1.28, meaning that its stock price is 28% more volatile than the broader market. Comparatively, Modular Medical has a beta of 0.51, meaning that its stock price is 49% less volatile than the broader market.

Modular Medical has lower revenue, but higher earnings than Nano-X Imaging. Modular Medical is trading at a lower price-to-earnings ratio than Nano-X Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nano-X Imaging	$13.02M	3.25	-$75.02M	-$2.14	N/A
Modular Medical	N/A	N/A	-$28.24M	-$8.69	N/A

Modular Medical has a net margin of 0.00% compared to Nano-X Imaging's net margin of -926.05%. Nano-X Imaging's return on equity of -116.93% beat Modular Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nano-X Imaging	-926.05%	-116.93%	-100.67%
Modular Medical	N/A	-292.14%	-222.79%

Nano-X Imaging presently has a consensus target price of $4.33, suggesting a potential upside of 705.75%. Given Nano-X Imaging's stronger consensus rating and higher possible upside, equities analysts clearly believe Nano-X Imaging is more favorable than Modular Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nano-X Imaging	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.50
Modular Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Modular Medical had 1 more articles in the media than Nano-X Imaging. MarketBeat recorded 2 mentions for Modular Medical and 1 mentions for Nano-X Imaging. Nano-X Imaging's average media sentiment score of 0.00 equaled Modular Medical'saverage media sentiment score.

Company	Overall Sentiment
Nano-X Imaging	Neutral
Modular Medical	Neutral

21.5% of Nano-X Imaging shares are held by institutional investors. Comparatively, 27.5% of Modular Medical shares are held by institutional investors. 7.7% of Nano-X Imaging shares are held by company insiders. Comparatively, 2.3% of Modular Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Nano-X Imaging beats Modular Medical on 11 of the 15 factors compared between the two stocks.

How does Modular Medical compare to Nyxoah?

Nyxoah (NASDAQ:NYXH) and Modular Medical (NASDAQ:MODD) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, media sentiment, valuation, risk, dividends and analyst recommendations.

27.5% of Modular Medical shares are owned by institutional investors. 17.1% of Nyxoah shares are owned by company insiders. Comparatively, 2.3% of Modular Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Modular Medical has a net margin of 0.00% compared to Nyxoah's net margin of -443.16%. Nyxoah's return on equity of -178.90% beat Modular Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nyxoah	-443.16%	-178.90%	-81.83%
Modular Medical	N/A	-292.14%	-222.79%

Modular Medical has lower revenue, but higher earnings than Nyxoah. Nyxoah is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nyxoah	$11.33M	4.65	-$101.92M	-$2.52	N/A
Modular Medical	N/A	N/A	-$28.24M	-$8.69	N/A

In the previous week, Nyxoah had 1 more articles in the media than Modular Medical. MarketBeat recorded 3 mentions for Nyxoah and 2 mentions for Modular Medical. Nyxoah's average media sentiment score of 0.95 beat Modular Medical's score of 0.00 indicating that Nyxoah is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nyxoah	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Modular Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Nyxoah currently has a consensus price target of $4.26, suggesting a potential upside of 213.38%. Given Nyxoah's stronger consensus rating and higher possible upside, research analysts plainly believe Nyxoah is more favorable than Modular Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nyxoah	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Modular Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Nyxoah has a beta of 1.65, suggesting that its share price is 65% more volatile than the broader market. Comparatively, Modular Medical has a beta of 0.51, suggesting that its share price is 49% less volatile than the broader market.

Summary

Nyxoah beats Modular Medical on 11 of the 15 factors compared between the two stocks.

How does Modular Medical compare to Spectral AI?

Spectral AI (NASDAQ:MDAI) and Modular Medical (NASDAQ:MODD) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, media sentiment, analyst recommendations, dividends and profitability.

In the previous week, Spectral AI had 1 more articles in the media than Modular Medical. MarketBeat recorded 3 mentions for Spectral AI and 2 mentions for Modular Medical. Spectral AI's average media sentiment score of 0.00 equaled Modular Medical'saverage media sentiment score.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Spectral AI	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Modular Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Spectral AI presently has a consensus target price of $4.00, suggesting a potential upside of 142.42%. Given Spectral AI's stronger consensus rating and higher possible upside, analysts clearly believe Spectral AI is more favorable than Modular Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
Modular Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Modular Medical has a net margin of 0.00% compared to Spectral AI's net margin of -69.27%. Spectral AI's return on equity of 0.00% beat Modular Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Spectral AI	-69.27%	N/A	-78.56%
Modular Medical	N/A	-292.14%	-222.79%

67.1% of Spectral AI shares are held by institutional investors. Comparatively, 27.5% of Modular Medical shares are held by institutional investors. 13.7% of Spectral AI shares are held by company insiders. Comparatively, 2.3% of Modular Medical shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Spectral AI has higher revenue and earnings than Modular Medical. Spectral AI is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Spectral AI	$19.65M	2.70	-$7.57M	-$0.35	N/A
Modular Medical	N/A	N/A	-$28.24M	-$8.69	N/A

Spectral AI has a beta of 1.21, meaning that its stock price is 21% more volatile than the broader market. Comparatively, Modular Medical has a beta of 0.51, meaning that its stock price is 49% less volatile than the broader market.

Summary

Spectral AI beats Modular Medical on 13 of the 15 factors compared between the two stocks.

How does Modular Medical compare to Envoy Medical?

Modular Medical (NASDAQ:MODD) and Envoy Medical (NASDAQ:COCH) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, profitability, dividends, valuation, earnings, risk and analyst recommendations.

Envoy Medical has a consensus target price of $2.17, suggesting a potential upside of 229.38%. Given Envoy Medical's stronger consensus rating and higher probable upside, analysts clearly believe Envoy Medical is more favorable than Modular Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Modular Medical	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

In the previous week, Envoy Medical had 4 more articles in the media than Modular Medical. MarketBeat recorded 6 mentions for Envoy Medical and 2 mentions for Modular Medical. Envoy Medical's average media sentiment score of 0.64 beat Modular Medical's score of 0.00 indicating that Envoy Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Modular Medical	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Envoy Medical	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

27.5% of Modular Medical shares are held by institutional investors. Comparatively, 8.6% of Envoy Medical shares are held by institutional investors. 2.3% of Modular Medical shares are held by company insiders. Comparatively, 7.2% of Envoy Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Envoy Medical has higher revenue and earnings than Modular Medical. Envoy Medical is trading at a lower price-to-earnings ratio than Modular Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Modular Medical	N/A	N/A	-$28.24M	-$8.69	N/A
Envoy Medical	$240K	211.56	-$23.76M	-$0.76	N/A

Modular Medical has a beta of 0.51, indicating that its share price is 49% less volatile than the broader market. Comparatively, Envoy Medical has a beta of 1.97, indicating that its share price is 97% more volatile than the broader market.

Modular Medical has a net margin of 0.00% compared to Envoy Medical's net margin of -11,304.83%. Envoy Medical's return on equity of 0.00% beat Modular Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Modular Medical	N/A	-292.14%	-222.79%
Envoy Medical	-11,304.83%	N/A	-144.13%

Summary

Envoy Medical beats Modular Medical on 12 of the 15 factors compared between the two stocks.

Get Modular Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MODD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

MODD vs. The Competition

Export

Metric	Modular Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$25.26M	$5.44B	$7.16B	$13.21B
Dividend Yield	N/A	1.78%	2.53%	16.37%
P/E Ratio	-0.31	25.57	274.15	26.16
Price / Sales	N/A	83.25	635.98	107.42
Price / Cash	N/A	31.87	76.38	53.09
Price / Book	0.98	5.93	11.21	6.34
Net Income	-$28.24M	$146.18M	$3.50B	$381.90M
7 Day Performance	33.99%	-0.38%	-0.90%	-1.41%
1 Month Performance	3.03%	-2.02%	-4.44%	-3.48%
1 Year Performance	-85.61%	5.08%	6.96%	1.16%

Modular Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
MODD Modular Medical	0.6141 of 5 stars	$2.72 +2.3%	N/A	-86.4%	$25.26M	N/A	N/A	51	News Coverage
OM Outset Medical	3.4511 of 5 stars	$3.00 -1.0%	$10.00 +233.3%	-73.2%	$56.39M	$117.80M	N/A	310
NNOX Nano-X Imaging	3.3329 of 5 stars	$0.69 +5.7%	$4.33 +524.8%	-86.9%	$54.51M	$15.63M	N/A	197
NYXH Nyxoah	3.1187 of 5 stars	$1.38 +0.7%	$4.26 +208.8%	-78.7%	$53.49M	$21.66M	N/A	154
MDAI Spectral AI	1.6767 of 5 stars	$1.66 +5.1%	$4.00 +141.0%	-32.7%	$53.43M	$15.39M	N/A	65

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:MODD) was last updated on 10/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Modular Medical (MODD) Competitors

MODD vs. OM, NNOX, NYXH, MDAI, and COCH

How does Modular Medical compare to Outset Medical?

Summary

How does Modular Medical compare to Nano-X Imaging?

Summary

How does Modular Medical compare to Nyxoah?

Summary

How does Modular Medical compare to Spectral AI?

Summary

How does Modular Medical compare to Envoy Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MODD vs. The Competition

Modular Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Modular Medical (MODD) Competitors

MODD vs. OM, NNOX, NYXH, MDAI, and COCH

How does Modular Medical compare to Outset Medical?

Which has more volatility and risk, OM or MODD?

Which has higher earnings & valuation, OM or MODD?

Does the media prefer OM or MODD?

Is OM or MODD more profitable?

Do institutionals and insiders hold more shares of OM or MODD?

Do analysts prefer OM or MODD?

Summary

How does Modular Medical compare to Nano-X Imaging?

Which has more risk & volatility, NNOX or MODD?

Which has stronger valuation and earnings, NNOX or MODD?

Is NNOX or MODD more profitable?

Do analysts rate NNOX or MODD?

Does the media prefer NNOX or MODD?

Do institutionals & insiders have more ownership in NNOX or MODD?

Summary

How does Modular Medical compare to Nyxoah?

Do institutionals and insiders hold more shares of NYXH or MODD?

Is NYXH or MODD more profitable?

Which has stronger valuation and earnings, NYXH or MODD?

Does the media favor NYXH or MODD?

Do analysts recommend NYXH or MODD?

Which has more volatility and risk, NYXH or MODD?

Summary

How does Modular Medical compare to Spectral AI?

Does the media favor MDAI or MODD?

Do analysts rate MDAI or MODD?

Is MDAI or MODD more profitable?

Do institutionals & insiders believe in MDAI or MODD?

Which has better valuation & earnings, MDAI or MODD?

Which has more volatility and risk, MDAI or MODD?

Summary

How does Modular Medical compare to Envoy Medical?

Do analysts recommend MODD or COCH?

Does the media refer more to MODD or COCH?

Do insiders and institutionals have more ownership in MODD or COCH?

Which has stronger valuation & earnings, MODD or COCH?

Which has more volatility & risk, MODD or COCH?

Is MODD or COCH more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

MODD vs. The Competition

Modular Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools